(Q34565294)

3 August 2017

0 references

The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans (English)

1 reference

3 August 2017

Joanna K Huxster

1

1 reference

3 August 2017

Alessandro Pirona

series ordinal

2

1 reference

3 August 2017

Michael J Morgan

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Journal of Psychopharmacology

3 August 2017

1 reference

3 August 2017

20

1 reference

3 August 2017

2

1 reference

3 August 2017

281-290

1 reference

Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA.

3 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

MDMA alters the response of the circadian clock to a photic and non-photic stimulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Mood state and brain electric activity in ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Ecstasy and the dance of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

The acute and sub-acute effects of 'ecstasy' (MDMA) on processing of facial expressions: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Ecstasy (MDMA) dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Mental disorders in ecstasy users: a prospective-longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

The development of a six-item daily self-report measure assessing identified depressive domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106060513

21 January 2018

Identifiers

DOI

10.1177/0269881106060513

1 reference

3 August 2017

1 reference